İçeriğe geç
akaturk Akademik ölçüm
Giriş yap Kayıt ol

Akademisyen

MURAT AKOVA

PROFESÖR

HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Araştırma konuları OpenAlex
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 199
YÖKSİS199 OpenAlex0
Proje 11
Kitap 10
Bildiri 35

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 10
h-indeks 9 Türkiye yüzdelik dilimi: 84 Üniversitesinde h-indekse göre 281. / 1.074
i10-indeks
9
Toplam atıf
402
Türkiye’de üst %13
Makale başına
40,2
FWCI
4,93
1,00 = dünya ortalaması
Dünyada üst %1
1
Dünyada üst %10
5

En çok atıf alan makaleleri

  1. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study 2023 dünyada üst %1 151 atıf
  2. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA) 2023 dünyada üst %10 49 atıf
  3. Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting 2022 dünyada üst %10 45 atıf

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 197
  • Q1 161
  • Q2 17
  • Q3 13
  • Q4 6
WoS (JCR) 197
  • Q1 133
  • Q2 35
  • Q3 9
  • Q4 21
TR Index TR Index

14 makale

OpenAlex atıf yüzdelik
  • Üst %1 1
  • Üst %10 5
  • Ort. 87.3%
  • n 10
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 194 Q1 159 Q2 17 Q3 12 Q4 6
  • YÖKSİS satırı 200

WoS (JCR)

  • Özet hariç 194 Q1 131 Q2 35 Q3 9 Q4 20
  • En iyi Q 197 Q1 133 Q2 35 Q3 8 Q4 21
  • YÖKSİS satırı 200

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

70 dergi
Scopus (SJR)
Q1 161 Q2 17 Q3 13 Q4 6
WoS (JCR)
Q1 133 Q2 35 Q3 9 Q4 21
TR Index
14 makale

Makale listesi

  1. 2025 Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia The Lancet Infectious Diseases DOI 10.1016/S1473-3099(25)00619-X YÖKSİS SJR Q1 JCR Q1
  2. 2025 Beyond conventional dosing: tailoring antimicrobial regimens for cachexia European Journal of Hospital Pharmacy DOI 10.1136/ejhpharm-2024-004250 YÖKSİS SJR Q1 JCR Q4
  3. 2025 Incorporating Ethics in Clinical Guidelines in Infectious Diseases: A Scoping Review JAMA Network Open DOI 10.1001/jamanetworkopen.2025.19826 YÖKSİS SJR Q1 JCR Q1
  4. 2025 Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis Antibiotics DOI 10.3390/antibiotics14070653 YÖKSİS SJR Q1 JCR Q1
  5. 2025 The challenge to improving and standardizing training in infectious diseases in Europe Clinical Microbiology and Infection DOI 10.1016/j.cmi.2025.03.007 YÖKSİS SJR Q1 JCR Q1
  6. 2025 Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database Intensive Care Medicine DOI 10.1007/s00134-025-07857-6 YÖKSİS SJR Q1 JCR Q1
  7. 2025 Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project Clinical Microbiology and Infection DOI 10.1016/j.cmi.2025.01.007 YÖKSİS SJR Q1 JCR Q1
  8. 2025 Risk factors for persistent candidemia and prognostic implications: Results from the ECMM Candida III study Journal of Infection DOI 10.1016/j.jinf.2025.106629 YÖKSİS SJR Q1 JCR Q1
  9. 2025 Effectiveness and Safety of Antibiotics in Kidney Transplant Recipients With Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis of Randomized Controlled Trials Open Forum Infectious Diseases DOI 10.1093/ofid/ofaf502 YÖKSİS SJR Q1 JCR Q2
  10. 2025 Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotic prophylaxis and empirical treatment Expert Review of Anti-infective Therapy DOI 10.1080/14787210.2025.2487149 YÖKSİS SJR Q1 JCR Q1
  11. 2025 Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe: A systematic review by the European Conference on Infections in Leukemia (ECIL) Journal of Infection DOI 10.1016/j.jinf.2025.106571 YÖKSİS SJR Q1 JCR Q1
  12. 2025 Infectious diseases ethics: a worldwide survey Clinical Microbiology and Infection DOI 10.1016/j.cmi.2024.10.021 YÖKSİS SJR Q1 JCR Q1
  13. 2025 Prevention and treatment of bacterial infections in patients with haematological cancers and haematopoietic stem cell transplantation: headways and shortcomings Clinical Microbiology and Infection DOI 10.1016/j.cmi.2024.09.015 YÖKSİS SJR Q1 JCR Q1
  14. 2025 Quantitative Immunoglobulin G and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in Türkiye Infectious Diseases and Clinical Microbiology DOI 10.36519/idcm.2025.546 YÖKSİS TR Index SJR Q4 JCR Q4
  15. 2024 Predictive modeling of mortality in carbapenem-resistant Acinetobacter baumannii bloodstream infections using machine learning Journal of Investigative Medicine DOI 10.1177/10815589241258964 YÖKSİS SJR Q2 JCR Q2
  16. 2024 Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy Microorganisms DOI 10.3390/microorganisms12040705 YÖKSİS SJR Q2 JCR Q2
  17. 2024 Hospital-acquired bloodstream infections in critically ill cirrhotic patients: a post-hoc analysis of the EUROBACT-2 international cohort study Annals of Intensive Care DOI 10.1186/s13613-024-01299-x YÖKSİS SJR Q1 JCR Q1
  18. 2024 Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies Expert Review of Anti-infective Therapy DOI 10.1080/14787210.2024.2408746 YÖKSİS SJR Q1 JCR Q1
  19. 2024 Current practice of screening and antimicrobial prophylaxis to prevent Gram-negative bacterial infection in high-risk haematology patients: results from a pan-European survey Therapeutic Advances in Infectious Disease DOI 10.1177/20499361241271863 YÖKSİS SJR Q1 JCR Q2
  20. 2024 Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B) International Journal of Infectious Diseases DOI 10.1016/j.ijid.2024.107161 YÖKSİS SJR Q1 JCR Q1

Akademisyenlere dön